Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335347 · ClinicalTrials.gov registry record · Phase 1
Safety Study of an Oral Vaccine to Prevent Avian Influenza
A Phase 1 study, sponsored by Vaxart.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT01335347 is a Phase 1 study that has completed, run by Vaxart. The registered enrollment target is 54 participants.
The verdict
NCT01335347, a Phase 1 study, has completed, sponsored by Vaxart.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and immunogenicity of an oral vaccine to prevent avian influenza. Volunteers will receive either one or two doses of research vaccine or placebo as part of this study.
Interventions
- BIOLOGICAL Placebo control
- BIOLOGICAL ND1.1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335347
The ClinicalTrials.gov registry entry for NCT01335347 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vaxart, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo control is the first listed.
NCT01335347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01335347 about?
NCT01335347 is a clinical study titled "Safety Study of an Oral Vaccine to Prevent Avian Influenza". The purpose of this study is to demonstrate the safety and immunogenicity of an oral vaccine to prevent avian influenza. Volunteers will receive either one or two doses of research vaccine or placebo as part of this study.
What is the current status of trial NCT01335347?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2011-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01335347?
The interventions under investigation include: Placebo control (BIOLOGICAL), ND1.1 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01335347?
This trial is sponsored by Vaxart, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.